CaMaPi for Adolescents/Young People With a History of Self-harm and Suicidal Ideation in Jos, Nigeria

Suicidal Ideation Clinical Trial

— CaMaPi  

Official title:

Culturally-adapted Manual-assisted Psychological Intervention (CaMaPi) for Adolescents/Young People With a History of Self-harm and Suicidal Ideation in Jos, Nigeria

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06440031
• Other study ID #: 0000-0001-5034-0335f
• Status: Not yet recruiting
• Phase: N/A
• Start date: July 1, 2024
• Est. completion date: September 30, 2025

Study information

• Verified date: May 2024
• Source: Nottingham Trent University
• Contact: Dung Jidong, PhD
• Phone: 07448930519
• Email: dung.jidong[@]mamnchester.ac.uk
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Suicide and self-harm are global disease burden that contributes significantly to years of lost life and mortality.

Description:

Self-harm and suicidal ideation represent a significant global public health concern (Knipe et al., 2022), affecting about 14.6 million people yearly (Nichols et al., 2021). Globally, over 700 000 people die by suicide annually (World Health Organization -- WHO, 2023).

Suicide is the fourth leading cause of death among 15-29-year-olds, and 77% of global suicides occur in low- and middle-income countries, including Nigeria (WHO, 2023). The psychological impact of suicidal ideation includes continuing high tendencies of self-harm (Jidong et al., 2024).

Despite the increasing rates of suicide and self-harm in Nigeria, this topic is understudied, with no culturally appropriate or sustainable psychological interventions.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 32
• Est. completion date: September 30, 2025
• Est. primary completion date: June 30, 2025
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 16 Years to 24 Years

Eligibility

Inclusion Criteria:

• Patients aged 16-24 years presenting to the participating services, and emergency departments or admitted after an episode of self-harm to the participating hospitals or self-referrals.

• Participants will have to be living within the catchment area of the participating practices, services and hospitals.

• Not needing inpatient psychiatric treatment.

Exclusion Criteria:

• Severe mental illness (such as Psychotic disorder).

• Conditions limiting engagement with assessment/intervention.

• Temporary resident unlikely to be available for follow up.

Related Conditions & MeSH terms

• Self-harm
• Self-Injurious Behavior
• Suicidal Ideation

Intervention

Behavioral:
• CaMaPi
CaMaPi is a manually assisted brief psychological intervention that is based on the principles of Cognitive Behaviour Therapy (CBT). The intervention includes psycho-education and a comprehensive cognitive behavioural assessment of the suicidal ideation and self-harm attempt using virtual stories of four young people to be delivered in 8-10 sessions for over three months

Other:
• TAU
Treatment as Usual (TAU) is routine care, such as diagnosis, assessment, psychotherapy, monitoring and any form of intervention (e.g., medication prescription) available at the collaborating service.

Locations

Country	Name	City	State
n/a

Sponsors (4)

Lead Sponsor	Collaborator
Nottingham Trent University	Jos University Teaching Hospital, Teesside University, University of Manchester

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in acceptance and satisfaction with the intervention	Primary outcome measure would be assessed using the Service Satisfaction Scale	Change is being assessed from baseline, end of intervention at 12 weeks, and at 12 weeks post-intervention
Secondary	Change in suicidal ideation	Secondary outcome measure would be assessed using the Beck Scale for Suicide Ideation	Change is being assessed from baseline, end of intervention at 12 weeks, and at 12 weeks post-intervention
Secondary	Change in hopelessness	Secondary outcome measure would be assessed using the Beck Hopelessness Scale	Change is being assessed from baseline, end of intervention at 12 weeks, and at 12 weeks post-intervention
Secondary	Change in Health Status	Secondary outcome measure would be assessed using the EQ-5D-5L quality of health scale	Change is being assessed from baseline, end of intervention at 12 weeks, and at 12 weeks post-intervention
Secondary	Change in repetition rate's of self-harm	Secondary outcome measure would be assessed using an adapted Suicide Attempt Self-Injury Interview	Change is being assessed from baseline, end of intervention at 12 weeks, and at 12 weeks post-intervention
Secondary	Change in use of health services	Secondary outcome measure would be assessed using Client Service Receipt Inventory	Change is being assessed from baseline, end of intervention at 12 weeks, and at 12 weeks post-intervention
Secondary	Change in psychological distress	Secondary outcome measure would be assessed using Kessler Psychological Distress Scale	Change is being assessed from baseline, end of intervention at 12 weeks, and at 12 weeks post-intervention